Xu Zhenyu 4

What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 608 shares in an open-market transaction on March 19, 2026. The weighted-average price reported was $4.78 per share (range $4.715–$4.87), for total proceeds of approximately $2,907. This sale was executed to satisfy tax withholding obligations related to the vesting of restricted stock units and was part of a pre-established Rule 10b5-1 trading plan, not a discretionary trade.

Key Details

• Transaction date: 2026-03-19 (Form 4 filed 2026-03-20 — timely filing)
• Shares sold: 608 shares; weighted-average price $4.78; price range $4.715–$4.87
• Total proceeds: ~$2,907
• Reason/footnotes: Sale to cover tax obligations from RSU vesting on 2026-03-18; executed under a pre-established Rule 10b5-1 plan (non-discretionary) (F1).
• Price disclosure: Column 4 is weighted average; reporter can provide per-trade breakdown on request (F2).
• Shares owned after transaction: Not specified in the provided excerpt.

Context
Sales to cover tax withholding for vested RSUs are routine and common for insiders and do not necessarily signal a change in sentiment about the company. The amount here is small (~$2.9k) and was conducted under a pre-set 10b5-1 plan, which generally indicates the trades were planned in advance rather than timed based on current company information.